Literature DB >> 21685360

Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.

David M Helfman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685360     DOI: 10.1093/jnci/djr221

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line.

Authors:  Benxu Cheng; Liza Doreen Morales; Yonghong Zhang; Shizue Mito; Andrew Tsin
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

2.  Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.

Authors:  Abhishek Gangrade; Vibha Pathak; Corinne E Augelli-Szafran; Han-Xun Wei; Patsy Oliver; Mark Suto; Donald J Buchsbaum
Journal:  Int J Mol Sci       Date:  2018-05-20       Impact factor: 5.923

Review 3.  S100A4 in cancer progression and metastasis: A systematic review.

Authors:  Fei Fei; Jie Qu; Mingqing Zhang; Yuwei Li; Shiwu Zhang
Journal:  Oncotarget       Date:  2017-05-19

4.  S100A4+ macrophages facilitate zika virus invasion and persistence in the seminiferous tubules via interferon-gamma mediation.

Authors:  Wei Yang; Yan-Hua Wu; Shuang-Qing Liu; Zi-Yang Sheng; Zi-Da Zhen; Rui-Qi Gao; Xiao-Yun Cui; Dong-Ying Fan; Zhi-Hai Qin; Ai-Hua Zheng; Pei-Gang Wang; Jing An
Journal:  PLoS Pathog       Date:  2020-12-14       Impact factor: 6.823

5.  Combined treatment with niclosamide and camptothecin enhances anticancer effect in U87 MG human glioblastoma cells.

Authors:  Laura Valdez; Benxu Cheng; Daniela Gonzalez; Reanna Rodriguez; Paola Campano; Andrew Tsin; Xiaoqian Fang
Journal:  Oncotarget       Date:  2022-05-05

Review 6.  S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction.

Authors:  Mathias Dahlmann; Dennis Kobelt; Wolfgang Walther; Giridhar Mudduluru; Ulrike Stein
Journal:  Cancers (Basel)       Date:  2016-06-20       Impact factor: 6.639

7.  Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers.

Authors:  R Kumar; L Coronel; B Somalanka; A Raju; O A Aning; O An; Y S Ho; S Chen; S Y Mak; P Y Hor; H Yang; M Lakshmanan; H Itoh; S Y Tan; Y K Lim; A P C Wong; S H Chew; T H Huynh; B C Goh; C Y Lim; V Tergaonkar; C F Cheok
Journal:  Nat Commun       Date:  2018-09-26       Impact factor: 14.919

8.  Interaction Behavior Between Niclosamide and Pepsin Determined by Spectroscopic and Docking Methods.

Authors:  Liuqi Guo; Xiaoli Ma; Jin Yan; Kailin Xu; Qing Wang; Hui Li
Journal:  J Fluoresc       Date:  2015-09-26       Impact factor: 2.217

9.  The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis.

Authors:  Alessia Serrano; Savina Apolloni; Simona Rossi; Serena Lattante; Mario Sabatelli; Mina Peric; Pavle Andjus; Fabrizio Michetti; Maria Teresa Carrì; Mauro Cozzolino; Nadia D'Ambrosi
Journal:  Cells       Date:  2019-10-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.